Dren Bio IPO

drenbio.com

Dren Bio researches and develops protein-based therapies in the treatment of cancer, autoimmune and other diseases.

Founded2019
Total Funding to Date$128.57MM
Register for Details

For more details on financing and valuation for Dren Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Dren Bio Ticker Symbol

Dren Bio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Dren Bio Stock Price

The stock price for Dren Bio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Dren Bio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/16/2022 Series B $62.5MM raised $XXX.XX $XXX.XX
10/16/2020 Series A $60MM raised $XXX.XX $XXX.XX
7/12/2019 Series Seed $6.07MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Dren Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector